A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To study the pharmacokinetics of test preparation and reference preparation irbesartan
tablets (0.15g/tablet) in a single oral administration in fasting and fed state,respectively,
in healthy adult subjects, and to evaluate the bioequivalence of the two preparations